Literature DB >> 8173153

Drug-induced torsades de pointes: a possible interaction of terfenadine and erythromycin.

K E Biglin, M S Faraon, T D Constance, M Lieh-Lai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8173153     DOI： 10.1177/106002809402800226

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  4 in total

1.  Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats.

Authors:  H Ohtani; C Taninaka; E Hanada; H Kotaki; H Sato; Y Sawada; T Iga
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 2.  Macrolide antibacterials. Drug interactions of clinical significance.

Authors:  N A von Rosensteil; D Adam
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

3.  Erythromycin, QTc interval prolongation, and torsade de pointes: Case reports, major risk factors and illness severity.

Authors:  Jules C Hancox; Mehrul Hasnain; W Victor R Vieweg; Michael Gysel; Michelle Methot; Adrian Baranchuk
Journal:  Ther Adv Infect Dis       Date:  2014-04

4.  The macrolide drug erythromycin does not protect the hERG channel from inhibition by thioridazine and terfenadine.

Authors:  Aziza El Harchi; Andrew S Butler; Yihong Zhang; Christopher E Dempsey; Jules C Hancox
Journal:  Physiol Rep       Date:  2020-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.